Medication Management Capacity and Its Neurocognitive Correlates in Huntington's Disease
- PMID: 30517595
- PMCID: PMC6849462
- DOI: 10.1093/arclin/acy093
Medication Management Capacity and Its Neurocognitive Correlates in Huntington's Disease
Abstract
Objective: Although medication management is a necessary daily activity for individuals with Huntington's disease (HD), medication management abilities and their relation to cognitive functioning have not been evaluated.
Method: Twenty individuals with HD and 20 healthy adults (HA) completed the Medication Management Abilities Assessment (MMAA). Individuals with HD also completed a self-report medication management measure and neuropsychological tests assessing executive function, retrospective memory, and prospective memory.
Results: Individuals with HD performed significantly poorer and made more undertaking errors on the MMAA as compared to HA. No group differences were found in overtaking errors. In the HD group, significant associations were found between undertaking errors and perceived medication management ability as well as between MMAA task performance and measures assessing prospective memory and executive functions.
Conclusions: Medication management capacity was negatively affected in individuals with HD and may be associated with difficulty remembering to take medications in the future.
Keywords: Everyday functioning; Executive functioning; Huntington’s disease; Learning and memory.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Medication Management Performance and Associated Cognitive Correlates in Healthy Older Adults and Older Adults with aMCI.Arch Clin Neuropsychol. 2019 May 1;34(3):290-300. doi: 10.1093/arclin/acy038. Arch Clin Neuropsychol. 2019. PMID: 29912269 Free PMC article.
-
Medication Management Performance in Parkinson's Disease: Examination of Process Errors.Arch Clin Neuropsychol. 2021 Oct 13;36(7):1307-1315. doi: 10.1093/arclin/acab004. Arch Clin Neuropsychol. 2021. PMID: 33621315
-
Cognitive deficits predict poorer functional capacity in Huntington's disease: but what is being measured?Neuropsychology. 2015 Mar;29(2):268-73. doi: 10.1037/neu0000134. Epub 2014 Aug 11. Neuropsychology. 2015. PMID: 25110931
-
Huntington's disease: update and review of neuropsychiatric aspects.Int J Psychiatry Med. 1994;24(3):189-208. doi: 10.2190/HU6W-3K7Q-NAEL-XU6K. Int J Psychiatry Med. 1994. PMID: 7890478 Review.
-
The role of prospective memory in medication adherence: a review of an emerging literature.J Behav Med. 2012 Feb;35(1):47-62. doi: 10.1007/s10865-011-9341-9. Epub 2011 Apr 13. J Behav Med. 2012. PMID: 21487722 Free PMC article. Review.
Cited by
-
Medication management and treatment adherence in Parkinson's disease patients with mild cognitive impairment.Acta Neurol Belg. 2023 Jun;123(3):823-829. doi: 10.1007/s13760-022-01916-1. Epub 2022 Mar 24. Acta Neurol Belg. 2023. PMID: 35325434
-
Prospective memory impairment in neurological disorders: implications and management.Nat Rev Neurol. 2021 May;17(5):297-307. doi: 10.1038/s41582-021-00472-1. Epub 2021 Mar 8. Nat Rev Neurol. 2021. PMID: 33686303 Review.
References
-
- Delis D. C., Kaplan E., & Kramer J. H. (2001). Delis–Kaplan executive function system: Examiner’s manual. San Antonio, TX: The Psychological Corporation.
-
- Heaton R. K., Chelune G. J., Talley J. L., Kay G. G., & Curtiss G. (1993). Wisconsin Card Sorting Test Manual Revised and Expanded. Odessa, FL: Psychological Assessment Resource.
-
- Hoth K. F., Paulsen J. S., Moser D. J., Tranel D., Clark L. A., & Bechara A. (2007). Patients with Huntington’s disease have impaired awareness of cognitive, emotional, and functional abilities. Journal of Clinical and Experimental Neuropsychology, 29, 365–376. 10.1080/13803390600718958. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical